发明名称 APOPTOSIS INHIBITOR
摘要 PROBLEM TO BE SOLVED: To obtain the subject inhibitor useful for the prophylaxis or therapy of diseases caused by excessive apoptosis such as viral diseases, e.g. AIDS, organ disorders, e.g. hepatitis or autoimmune diseases by including a specific compound having inhibiting actions on both the production of an Fas ligand and the production of a tumor necrosis factor-α. SOLUTION: This inhibitor is obtained by including a condensed ring compound of a 7-membered ring comprising a triazepine or a diazepine and a 5 membered ring containing 2-4 nitrogen atoms having inhibiting actions on both the production of an Fas ligand and the production of a tumor necrosis factor-α.6-(4-Bromophenyl)-4-(4-methoxybenzyl)-1-methyl-4H-2,3,4,5,10b- pentaazabenzo[e]azulene, etc., are cited as the condensed ring compound. The inhibitor is usually systemically or locally and orally or parenterally administered and the dose thereof is usually 0.01-1,000 mg for an adult administered once to several times a day.
申请公布号 JPH11228576(A) 申请公布日期 1999.08.24
申请号 JP19970365239 申请日期 1997.12.18
申请人 JAPAN TOBACCO INC 发明人 NAKAMURA TAKESHI;ISOJIMA HIROTAKA;MARUHASHI JIYUNJI;BABA MASANORI
分类号 C07D487/04;A61K31/55;A61P31/12;A61P31/18;A61P43/00;C07D495/14;(IPC1-7):C07D487/04 主分类号 C07D487/04
代理机构 代理人
主权项
地址